SEC Filing Details
SEC Filing Details
Document Details
Form
Filing Date
Dec 13, 2018
Document Date
Dec 12, 2018
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Akebia Therapeutics
Issuer
Akebia Therapeutics, Inc.
Filer
Enyedy Mark J
Print Page
Email Page
Contact IR
Email Alerts
Tear Sheet
Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142
+1 617.871.2098 phone
+1 617.871.2099 fax